You are searching for: hsa04613

---

T99149 Target Info	Target Name	HUMAN ERK activator kinase 2 (MEK2)
	Target type	. Target
	Disease	Metastatic melanoma; Neurofibromatosis type 1;
	Drugs	Trametinib	Drug Info

T34318 Target Info	Target Name	Cathelicidin antimicrobial peptide (CAMP)
	Target type	Successful Target
	Disease	Asthma;
	Drugs	Colforsin daropate hci	Drug Info

T68461 Target Info	Target Name	Adenine nucleotide translocator 1 (SLC25A4)
	Target type	Successful Target
	Disease	Hypercalcaemia;
	Drugs	Clodronate	Drug Info

T60708 Target Info	Target Name	Complement C5 (CO5)
	Target type	Successful Target
	Disease	Large B Cell Lymphoma; Geographic atrophy;
	Drugs	Pozelimab	Drug Info

T22274 Target Info	Target Name	Histone deacetylase 6 (HDAC6)
	Target type	Clinical trial Target
	Disease	Multiple myeloma; Solid tumour/cancer;
	Drugs	Citarinostat	Drug Info

T35940 Target Info	Target Name	ERK activator kinase 1 (MEK1)
	Target type	Clinical trial Target
	Disease	Melanoma; Thyroid cancer;
	Drugs	Selumetinib	Drug Info

T51191 Target Info	Target Name	Histone deacetylase 2 (HDAC2)
	Target type	Clinical trial Target
	Disease	Lymphoma; Dermatitis;
	Drugs	CHR-3996	Drug Info

T67619 Target Info	Target Name	RAC-alpha serine/threonine-protein kinase (AKT1)
	Target type	Successful Target
	Disease	Triple negative breast cancer; Colorectal cancer;
	Drugs	Capivasertib	Drug Info

T86385 Target Info	Target Name	Cathepsin G (CTSG)
	Target type	Clinical trial Target
	Disease	Chronic obstructive pulmonary disease; Neurological disorder;
	Drugs	JNJ-10311795	Drug Info

T89055 Target Info	Target Name	ERK activator kinase 2 (MEK2)
	Target type	Clinical trial Target
	Disease	Melanoma; Thyroid cancer;
	Drugs	Selumetinib	Drug Info

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.